Evidence map›Paper›PMID 28045347›Full record

ArticlePsychiatric services (Washington, D.C.)2017

Depression Treatment Among Elderly Medicare Beneficiaries With Incident Cases of Cancer and Newly Diagnosed Depression.

Monira Alwhaibi, Suresh Madhavan, Thomas Bias, Kimberly Kelly, Jamie Walkup, Usha Sambamoorthi

Open access · bronzeAbstract read
In one paragraph

Article in Psychiatric services (Washington, D.C.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Monira AlwhaibiDr. Alwhaibi, Dr. Madhavan, Dr. Bias, Dr. Kelly, and Dr. Sambamoorthi are with the School of Pharmacy, West Virginia University, Morgantown, and Dr. Alwhaibi is also with the School of Pharmacy, King Saud University, Riyadh, Saudi Arabia (e-mail: mmalwhaibi@mix.wvu.edu ). Dr. Walkup is with the Graduate School of Applied and Professional Psychology, Rutgers University, New Brunswick, New Jersey.
Suresh MadhavanDr. Alwhaibi, Dr. Madhavan, Dr. Bias, Dr. Kelly, and Dr. Sambamoorthi are with the School of Pharmacy, West Virginia University, Morgantown, and Dr. Alwhaibi is also with the School of Pharmacy, King Saud University, Riyadh, Saudi Arabia (e-mail: mmalwhaibi@mix.wvu.edu ). Dr. Walkup is with the Graduate School of Applied and Professional Psychology, Rutgers University, New Brunswick, New Jersey.
Thomas BiasDr. Alwhaibi, Dr. Madhavan, Dr. Bias, Dr. Kelly, and Dr. Sambamoorthi are with the School of Pharmacy, West Virginia University, Morgantown, and Dr. Alwhaibi is also with the School of Pharmacy, King Saud University, Riyadh, Saudi Arabia (e-mail: mmalwhaibi@mix.wvu.edu ). Dr. Walkup is with the Graduate School of Applied and Professional Psychology, Rutgers University, New Brunswick, New Jersey.
Kimberly KellyDr. Alwhaibi, Dr. Madhavan, Dr. Bias, Dr. Kelly, and Dr. Sambamoorthi are with the School of Pharmacy, West Virginia University, Morgantown, and Dr. Alwhaibi is also with the School of Pharmacy, King Saud University, Riyadh, Saudi Arabia (e-mail: mmalwhaibi@mix.wvu.edu ). Dr. Walkup is with the Graduate School of Applied and Professional Psychology, Rutgers University, New Brunswick, New Jersey.
Jamie WalkupDr. Alwhaibi, Dr. Madhavan, Dr. Bias, Dr. Kelly, and Dr. Sambamoorthi are with the School of Pharmacy, West Virginia University, Morgantown, and Dr. Alwhaibi is also with the School of Pharmacy, King Saud University, Riyadh, Saudi Arabia (e-mail: mmalwhaibi@mix.wvu.edu ). Dr. Walkup is with the Graduate School of Applied and Professional Psychology, Rutgers University, New Brunswick, New Jersey.
Usha SambamoorthiDr. Alwhaibi, Dr. Madhavan, Dr. Bias, Dr. Kelly, and Dr. Sambamoorthi are with the School of Pharmacy, West Virginia University, Morgantown, and Dr. Alwhaibi is also with the School of Pharmacy, King Saud University, Riyadh, Saudi Arabia (e-mail: mmalwhaibi@mix.wvu.edu ). Dr. Walkup is with the Graduate School of Applied and Professional Psychology, Rutgers University, New Brunswick, New Jersey.
Wallonie-Bruxelles International · BE

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Sally Lynn Hodder · 2012 to 2026
$81.0M
NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

objectiveDepression treatment can improve the health outcomes of elderly cancer survivors. There is a paucity of studies on the extent to which depression is treated among elderly cancer survivors. Therefore, this study estimated the rates of depression treatment among elderly cancer survivors and identified the factors affecting depression treatment.

methodsA retrospective cohort study design was adopted, and data were obtained from the linked Surveillance, Epidemiology and End Results (SEER) and Medicare database. Elderly individuals (≥ 66 years) with incident cases of breast, colorectal, or prostate cancer and newly diagnosed depression (N=1,673) were followed for six months after the depression diagnosis to identify depression treatment (antidepressants only, psychotherapy only, combined treatment with both antidepressants and psychotherapy, and no depression treatment). Chi-square tests and multinomial logistic regressions were used to analyze the factors associated with depression treatment.

resultsIn this study population, 46% received antidepressants only, 27% received no treatment, 18% received combined therapy, and 9% received psychotherapy only. Factors associated with depression treatment included anxiety, the percentage of psychologists at the county level, the number of visits to primary care physicians, ongoing cancer treatment, the presence of other chronic conditions, and race-ethnicity.

conclusionsThe study findings indicate that two-thirds of cancer survivors received depression treatment in the first six months after depression diagnosis. Our study findings indicate that racial-ethnic disparities in depression treatment persist and competing demands for cancer treatment may take priority over depression care. Also, the availability of psychologists may influence receipt of psychotherapy among cancer survivors.

Indexed as

Breast NeoplasmsColorectal NeoplasmsProstatic NeoplasmsAgedAged, 80 and overAntidepressive AgentsCancer SurvivorsCombined Modality TherapyComorbidityDepressive DisorderFemaleFollow-Up StudiesHumansMaleMedicarePsychotherapyAntidepressive AgentsCancerDepressionElderlySEER-MedicareTreatment

Identifiers

PMID28045347
PMCPMC5513147
OpenAlexW2563793610

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.